Sleder Anna T, Kalus James, Lanfear David E
Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA.
Department of Pharmacy, Henry Ford Hospital, Detroit, MI, USA.
J Cardiovasc Pharmacol Ther. 2016 Jan;21(1):20-6. doi: 10.1177/1074248415590196. Epub 2015 Jun 8.
Current clinical cardiovascular practice requires a clinician to have a strong foundation in multiple aspects of pharmacology. Modern cardiovascular regimens are complex, and optimal management, application of evolving guidelines, and adoption of new therapies build off a more basic understanding of pharmacokinetics and pharmacodynamics. In addition, it is likely time to add a third pillar into this discussion, the expanding field of pharmacogenomics referring to the genetic influences on drug response. This field has increasing applications in medicine and clearly holds significant promise for cardiovascular disease management. Awareness of pharmacogenomic advances and the fundamentals of pharmacokinetics and pharmacodynamics can help the clinician more easily deliver great care. Here we attempt to briefly summarize and simplify key concepts of pharmacokinetics, pharmacodynamics, and pharmacogenomics relevant to the cardiovascular disease practitioner.
当前的临床心血管实践要求临床医生在药理学的多个方面有坚实的基础。现代心血管治疗方案很复杂,最佳管理、不断演变的指南的应用以及新疗法的采用都建立在对药代动力学和药效学更基本的理解之上。此外,可能是时候在这个讨论中增加第三个支柱了,即不断扩展的药物基因组学领域,它指的是基因对药物反应的影响。这个领域在医学中的应用越来越多,显然对心血管疾病管理有着巨大的前景。了解药物基因组学的进展以及药代动力学和药效学的基本原理可以帮助临床医生更轻松地提供优质护理。在这里,我们试图简要总结并简化与心血管疾病从业者相关的药代动力学、药效学和药物基因组学的关键概念。